PRODUCT COMPARISON · ADULTS 21+
Compare labels, formats and batch information
A product name cannot tell you which kratom product is appropriate for you. Start with the current ingredients, format, label warnings and batch information. We cannot recommend a strain as a treatment or predict an individual’s response.
Powder, capsules or extracts?
- Plain leaf powder: measure by weight with an accurate scale. Spoonfuls vary and do not provide a reliable measurement.
- Powder capsules: our capsules contain 500 mg of powder each. Capsule count measures powder weight, not a verified alkaloid amount.
- Extract liquids and tablets: read the total mitragynine content and the labeled serving fraction or volume. Milligrams of extract are not the same as milligrams of mitragynine.
- Combination products: check all ingredients. Kratom, kava and kanna products need their own label precautions; do not assume a plain-leaf serving applies.
How to interpret colors and strain names
Red, green, white and gold are commercial descriptions, not standardized medical categories. Names such as Maeng Da, Bali, Hulu and Malay vary across suppliers and batches; they do not guarantee origin, strength or a specific effect. “Fast,” “slow,” “morning” and “night” descriptions should not be treated as reliable dosing or treatment instructions.
Our signature blends combine leaf products. A blend name does not establish that it is stronger, safer, better for sleep, or suitable for pain or another health condition.
Serving information
Our plain-leaf serving guidance is 3 grams of powder or 4–6 capsules containing 500 mg each (2–3 grams of powder). At a batch potency of 1.5% mitragynine, these amounts calculate to approximately 45 mg and 30–45 mg of mitragynine, respectively. Actual content depends on the batch; 1.5% is not a guarantee for every product.
Our store uses a maximum of 50 mg mitragynine per serving for products with confirmed content. This ceiling is not a proven safe dose, a suggested starting amount or a daily allowance. Follow a lower labeled serving when provided. Do not increase amounts to chase an effect or combine products to work around a serving limit.
Serving and label guide · Batch test information · Frequently asked questions · Contact our team
Testing and label questions
Match the report to the lot or batch you have. Review measured alkaloid content and the contaminants actually tested. If a label, ingredient or serving amount is unclear, contact us before use. Testing does not establish that a product is risk-free.
Important safety information
Some people who use kratom regularly develop dependence and experience withdrawal when stopping. Nausea, constipation, dizziness, and drowsiness have been reported. Rare but serious events, including seizures and liver injury, have also been reported in people using kratom. Some reports involve other substances, varying product composition, or incomplete information, which can make the cause difficult to determine. These limitations do not establish that kratom is risk-free or rule out its contribution to harm.
For adults 21+ only. Do not use during pregnancy or breastfeeding. Do not combine kratom with alcohol, opioids or other drugs. Discuss medications and health conditions with a qualified healthcare professional before use. Do not drive or operate machinery after use. Keep products out of reach of children.
Stop use and seek medical advice if you experience an adverse reaction. Call 911 for trouble breathing, a seizure, collapse or loss of consciousness. Seek prompt medical care for yellowing of the skin or eyes, dark urine, or persistent vomiting.
Read the evidence
NIH: kratom research and safety · FDA information on kratom
Information reviewed October 3, 2026. Research continues to develop. This page provides general information and does not replace professional medical advice. Our products are not intended to diagnose, treat, cure or prevent any disease.